The €1.2 Million Bet on Casein Without the Cow

There is a cow in the Netherlands that never needs feeding, never gets sick, and never needs milking. It is called Margaret, it is made of stainless steel, and it is the flagship fermenter of Those Vegan Cowboys, a precision fermentation startup that makes dairy proteins without animals. This month, Margaret got a new job description: sports nutrition.

Those Vegan Cowboys has teamed up with dairy supplier Interfood, the Dutch applied research institute HAS green academy, and sports nutrition brand XXL Nutrition in a project that secured more than €1.2 million in subsidy money from OPZuid, the European Union's regional development programme for the south of the Netherlands. With the partners' own contributions in research capacity, personnel, and development work added on, the total budget comes to approximately €2.58 million, and the work is scheduled to run until March 2028.

Prototypes, not products, yet

To be clear about what the money buys: this is a research and development programme, not a product launch. The four partners will study how precision-fermented casein behaves in food products, develop prototypes aimed at the sports nutrition market, and run consumer research to find out what shoppers actually expect from these ingredients. The formats on the table are familiar ones: high-protein drinks, shakes, powders, and bars.

The consortium is built as a complete chain. Those Vegan Cowboys develops and produces the caseins. Interfood contributes its knowledge of dairy proteins, ingredients, and applications from international nutrition markets. HAS green academy brings practice-based research and knowledge sharing, including its Protein Transition in Nutrition research group. XXL Nutrition supplies sports nutrition expertise, consumer knowledge, and a direct route toward actual products.

The project also marks a shift in the startup's ambitions. Until now, cheese has been the first application for its recombinant casein: the company is working with more than ten food companies, including dairy majors Westland Kaas and Hochland, on mozzarella, Camembert, feta, burger cheeses, and aged varieties, plus chocolate bars and coatings. In July, it established Margaret's Finest, a discovery programme named for the fermenter (which is in turn named after former British prime minister Margaret Thatcher) to explore applications beyond cheese. Sports nutrition is the first new territory under that programme.

Why casein, and why the gym

Casein is milk protein's slow half. Whey delivers amino acids into the bloodstream quickly, while casein forms a gel in the stomach and releases its amino acids over hours. That property is what makes casein interesting for recovery: an athlete's muscles rebuild over a long window, including overnight, which is a poor fit for fast-acting whey. The consortium's bet is that slow-release protein is a genuine white space in a sports nutrition market built around speed.

Timing matters because the economics of conventional protein are getting uncomfortable. Sports nutrition stakeholders are hunting for alternatives to whey amid surging prices driven by the mainstreaming of protein in everyday diets, alongside new demand from people using GLP-1 medicines. Mathias Jansen, brand manager at XXL Nutrition, pointed to strong consumer demand for high-quality amino acid profiles with better digestibility and tolerability, including for lactose-intolerant consumers, since animal-free casein is completely lactose-free by construction.

There is also a design argument. Precision fermentation means the protein composition is not fixed the way a cow's milk is: the consortium plans to investigate individual caseins, different combinations, and even caseins from species other than cows to see whether they offer better functional or nutritional properties for specific groups of athletes. Whether that flexibility translates into genuinely better products is an open question, and the honest answer from the partners is that exploration, not a predetermined product, is the point of the next two years.

The pitch is not another vegan protein powder. It is a dairy protein, unmoored from the dairy cow, being tuned for the one thing athletes will reliably pay for: recovery.

The regulatory chessboard

Where this protein can be sold, and when, depends on geography. Those Vegan Cowboys has already self-affirmed its alpha-S1 casein as Generally Recognized as Safe (GRAS) in the United States and expects a no questions letter from the Food and Drug Administration later this year. The partners say the US will be the first commercial launch market. That plan overlaps neatly with XXL Nutrition's own trajectory: the brand has been in talks with Walmart about a potential collaboration that could put its products into 4,000 stores.

Europe is a longer road. Precision-fermented casein will require authorization under the EU's Novel Foods regulation, a process the partners say will take at least three years. Their answer is to run product development and regulatory approval in parallel: research the proteins, develop applications, validate functionality, while the dossier moves through Brussels. The startup has also said it intends to file for approval in Singapore and the UK, noting that an EU green light could ease the British process under the recently signed sanitary and phytosanitary agreement.

Reasons to keep the skepticism handy

The demand story the companies tell is more nuanced than a press release suggests. Hille van der Kaa, the startup's CEO, told NutraIngredients that consumer demand for vegan and plant-based claims has tapered since the company launched in 2020. What has grown is demand from industry stakeholders for sustainable alternatives, plus retailer appetite for lower carbon dioxide claims, which matter for European grocers. Perhaps most tellingly, she said the industry has asked for an alternative because it expects conventional casein prices to rise in the future. That is less a revolution than a hedge, and a refreshingly honest one.

The economics still have to be proven at scale. The company says its microbes produce casein five times more efficiently than a traditional dairy cow, and that its process cuts carbon dioxide emissions by 95 percent while using one fifth of the land and water of cow-derived casein. Those are company-reported figures, and they sit alongside a sector where consumer awareness of fermentation-derived foods remains low and capital is concentrating on firms with clear commercialization paths. The startup recently raised €12.25 million in equity and crowdfunding, which suggests investors are willing to fund the long road. But nothing from this project is on a shelf yet, and the shelf is what matters.

What makes this story worth watching is the discipline of it. There is no claim that cow-free casein will replace dairy, no date promised for a flagship product, and no pretense that European regulators move quickly. There is a €2.58 million programme, a clear timeline to March 2028, and a specific technical question: can a slow protein made without a cow earn its place in the gym bag? That is a testable proposition, which is more than most food-tech announcements offer.